Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network

被引:2
|
作者
Ventoso, Michael [1 ]
Norton, Kerri-Ann [1 ]
机构
[1] Bard Coll, Div Sci Math & Comp, Annandale On Hudson, NY 12504 USA
关键词
cancer; modeling; angiogenesis; T-cell; lymphocyte; MIGRATION; SURVIVAL;
D O I
10.1109/BIBM49941.2020.9313463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytotoxic T-cells (CTLs) are one mechanism the immune system employs to eliminate cancer cells. In this study, we expand upon a previous 3-dimensional agent-based model of triple-negative breast cancer to include an immuno-therapy in the form of a CTL insertion into the tumor. The model consists of a triple-negative breast tumor, comprised of progenitor cells, cancer stem cells, tumor-associated macrophages, as well as an expanding vascular network. We investigate the treatment effects of inserting different numbers of CTLs into the tumor microenvironment, and their overall effect on tumor size in the short and longer terms. The results show that while CTLs decrease the size of the tumor they are ineffective at completely eliminating it, leading to continued tumor proliferation in the aftermath.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 50 条
  • [1] The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
    Ji Eun Choi
    Jae Seok Lee
    Min-Sun Jin
    Ilias P. Nikas
    Kwangsoo Kim
    Sunah Yang
    Soo Young Park
    Jiwon Koh
    Sohyeon Yang
    Seock-Ah Im
    Han Suk Ryu
    Breast Cancer Research, 25
  • [2] The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
    Choi, Ji Eun
    Lee, Jae Seok
    Jin, Min-Sun
    Nikas, Ilias P.
    Kim, Kwangsoo
    Yang, Sunah
    Park, Soo Young
    Koh, Jiwon
    Yang, Sohyeon
    Im, Seock-Ah
    Ryu, Han Suk
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [3] Prognostic model based on tumor stemness genes for triple-negative breast cancer
    Ouyang, Min
    Gui, Yajun
    Li, Namei
    Zhao, Lin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    James Isaacs
    Carey Anders
    Heather McArthur
    Jeremy Force
    Current Treatment Options in Oncology, 2021, 22
  • [5] Circulating microRNAs and their role in the immune response in triple-negative breast cancer
    Pina-Sanchez, Patricia
    Valdez-Salazar, Hilda-Alicia
    Ruiz-Tachiquin, Martha-Eugenia
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [6] Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Yam, Clinton
    Yen, Er-Yen
    Chang, Jeffrey T.
    Bassett, Roland L., Jr.
    Alatrash, Gheath
    Garber, Haven
    Huo, Lei
    Yang, Fei
    Philips, Anne, V
    Ding, Qing-Qing
    Lim, Bora
    Ueno, Naoto T.
    Kannan, Kasthuri
    Sun, Xiangjie
    Sun, Baohua
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    White, Jason B.
    Ravenberg, Elizabeth
    Seth, Sahil
    Guerriero, Jennifer L.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer K.
    Wargo, Jennifer A.
    Hortobagyi, Gabriel N.
    Futreal, Andrew
    Wistuba, Ignacio I.
    Sun, Ryan
    Moulder, Stacy L.
    Mittendorf, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5365 - 5375
  • [7] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    Isaacs, James
    Anders, Carey
    McArthur, Heather
    Force, Jeremy
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [8] Triple-negative breast Cancer risk: Ancestry and immune response.
    Ford, Marvella E.
    Brown, Erika T.
    Turner, David P.
    Findlay, Victoria J.
    Esnaola, Nestor F.
    Alberg, Anthony J.
    Bolick, Susan
    Hurley, Deborah
    Kramer, Rita
    Salley, Judith D.
    Cunningham, Joan E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 66 - 66
  • [9] Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer
    Zheng, Shaoquan
    Zou, Yutian
    Liang, Jie-ying
    Xiao, Weikai
    Yang, Anli
    Meng, Tiebao
    Lu, Shilin
    Luo, Zhongbing
    Xie, Xiaoming
    MOLECULAR ONCOLOGY, 2020, 14 (11) : 2814 - 2833
  • [10] Immune Cell Subtyping in Indian Triple-Negative Breast Cancer Tumor Microenvironment with Variable Treatment Response
    Vaid, P.
    Yadav, D.
    Kanase, P.
    Kadu, S.
    Kelkar, D.
    Shashidhara, L.
    Koppiker, C.
    Kulkarni, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S94 - S94